Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale Director sold 10,998 shares at an average $23.82 ($261,981)
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 3/A Insider 3/A
  8. 4 Planned sale SVP, General Counsel sold 332 shares at $310.72 ($103,159)
  9. 8-K Event Other events
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 144 Insider Sale of Securities
  12. S-3ASR Offering Registration Statement
  13. S-3ASR Offering Registration Statement
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. ARS Other Annual Report to Security Holders
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 6 of 64 · 1,278 filings